Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31(2):107–25.

Article  CAS  PubMed  Google Scholar 

Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–63.

Article  PubMed  Google Scholar 

Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dos Santos AF, Fazeli G, Da Silva TNX, Angeli JPF. Ferroptosis: mechanisms and implications for cancer development and therapy response. Trend Cell Biol. 2023;33(12):1062–76.

Article  CAS  Google Scholar 

Qiu Y, Cao Y, Cao W, Jia Y, Lu N. The application of ferroptosis in diseases. Pharmacol Res. 2020;159:104919.

Article  CAS  PubMed  Google Scholar 

Dixon SJ, Pratt DA, Ferroptosis. A flexible constellation of related biochemical mechanisms. Mol Cell. 2023;83(7):1030–42.

Article  CAS  PubMed  Google Scholar 

Tang D, Kroemer G. Ferroptosis. Curr Biol. 2020;30(21):R1292-7.

Article  CAS  PubMed  Google Scholar 

Liu J, Xia X, Huang P. xCT: a critical molecule that links cancer metabolism to redox signaling. Mol Ther. 2020;28(11):2358–66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang C, Yang M, Deng J, Li P, Su W, Jiang R. Upregulation and activation of p53 by erastin-induced reactive oxygen species contribute to cytotoxic and cytostatic effects in A549 lung cancer cells. Oncol Rep. 2018;40(4):2363–70.

CAS  PubMed  Google Scholar 

Jiang L, Kon N, Li T, Wang SJ, Su T, Hibshoosh H. Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015;520(7545):57–62.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019;575(7784):688–92.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Y, Shi J, Liu X, Feng L, Gong Z, Koppula P. BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat Cell Biol. 2018;20(10):1181–92.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roh JL, Kim EH, Jang H, Shin D. Aspirin plus sorafenib potentiates cisplatin cytotoxicity in resistant head and neck cancer cells through xCT inhibition. Free Radic Biol Med. 2017;104:1–9.

Article  CAS  PubMed  Google Scholar 

Otsuki Y, Yamasaki J, Suina K, Okazaki S, Koike N, Saya H. Vasodilator oxyfedrine inhibits aldehyde metabolism and thereby sensitizes cancer cells to xCT-targeted therapy. Cancer Sci. 2020;111(1):127–36.

Article  CAS  PubMed  Google Scholar 

Okazaki S, Umene K, Yamasaki J, Suina K, Otsuki Y, Yoshikawa M. Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma. Cancer Sci. 2019;110(11):3453–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu L, Liu R, Liu Y, Li G, Chen Q, Liu X. Cystine-glutamate antiporter xCT as a therapeutic target for cancer. Cell Biochem Funct. 2021;39(2):174–9.

Article  PubMed  Google Scholar 

Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021;12(8):599–620.

Article  CAS  PubMed  Google Scholar 

Ji X, Qian J, Rahman SMJ, Siska PJ, Zou Y, Harris BK. xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression. Oncogene. 2018;37(36):5007–19.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li S, He Y, Chen K, Sun J, Zhang L, He Y. RSL3 drives ferroptosis through NF-kappaB pathway activation and GPX4 depletion in glioblastoma. Oxid Med Cell Longev. 2021;2021:2915019.

Article  PubMed  PubMed Central  Google Scholar 

Woo JH, Shimoni Y, Yang WS, Subramaniam P, Iyer A, Nicoletti P. Elucidating compound mechanism of action by network perturbation analysis. Cell. 2015;162(2):441–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sui X, Zhang R, Liu S, Duan T, Zhai L, Zhang M. RSL3 drives ferroptosis through GPX4 inactivation and ROS production in colorectal cancer. Front Pharmacol. 2018;9:1371.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156(1–2):317–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang K, Zhang Z, Tsai HI, Liu Y, Gao J, Wang M. Branched-chain amino acid aminotransferase 2 regulates ferroptotic cell death in cancer cells. Cell Death Differ. 2021;28(4):1222–36.

Article  CAS  PubMed  Google Scholar 

Conrad M, Pratt DA. The chemical basis of ferroptosis. Nat Chem Biol. 2019;15(12):1137–47.

Article  CAS  PubMed  Google Scholar 

Reczek CR. Chandel NS. ROS promotes cancer cell survival through calcium signaling. Cancer Cell. 2018;33(6):949–51.

Article  CAS  PubMed  Google Scholar 

Schieber M, Chandel NS. ROS function in redox signaling and oxidative stress. Curr Biol. 2014;24(10):R453–462.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pope LE, Dixon SJ. Regulation of ferroptosis by lipid metabolism. Trend Cell Biol. 2023;33(12):1077–87.

Article  CAS  Google Scholar 

Haeggström JZ, Funk CD. Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease. Chem Rev. 2011;111(10):5866–98.

Article  PubMed  Google Scholar 

Zou Y, Li H, Graham ET, Deik AA, Eaton JK, Wang W. Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis. Nat Chem Biol. 2020;16(3):302–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gaschler MM, Hu F, Feng H, Linkermann A, Min W, Stockwell BR. Determination of the subcellular localization and mechanism of action of ferrostatins in suppressing ferroptosis. ACS Chem Biol. 2018;13(4):1013–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Skouta R, Dixon SJ, Wang J, Dunn DE, Orman M, Shimada K. Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models. J Am Chem Soc. 2014;136(12):4551–6.